Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.

Strengthening brand perception through real-time insights from ophthalmologists at conference

Our client wished to conduct conference research to evaluate reactions to their ophthalmic technology as a result of a new product launch, to measure awareness of their other portfolio of products within ophthalmology and see how they compared to competitors.

They particularly wanted to gather feedback and interest from physicians attending the conference in real-time as well as measure recall of their products.

read more »

Taking a holistic view when exploring compliance

Our client wanted to address the issues and barriers surrounding non-compliance with their biologic drug.

The assumption going into the study was that the barriers to compliance existed among the patients themselves. We therefore employed a one-to-one methodology with patients who were recruited to represent the various stages in the patient journey as they transitioned to biologics. However, we also felt it was important to gain the perspectives of the healthcare professional managing the patients in order to gain a more holistic view of the patient experience.

read more »

  • Posted by John Branston
  • January 30, 2014
  • Videos

Mobile Research

John Branston discusses the opportunities presented by mobile market research within healthcare.

Our digital and mobile expert, Director John Branston discusses the benefits of mobile research and how they can lead to new and better patient and physician insight.

read more »

  • Posted by Julie Denny
  • December 3, 2013
  • News

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

In a recent study, physicians predicted that current market leaders Enbrel (etanercept) and Humira (adalimumab) will continue to lose market share to newer biologics such as RoActemra (tocilizumab), Orencia (abatacept) and Simponi (golimumab) and may experience strong competition from biosimilar agents and pipeline products with novel mechanisms of action, including small molecules.

read more »

  • Posted by Jennifer Redfearn, Research Manager
  • June 16, 2013
  • Blogs

Cultural understanding starts with a cup of tea

Cultural understanding starts with a cup of tea

If you ever have the chance, ask market researchers about their food experiences at central location facilities around the world. They will usually be able to recount a funny anecdote or two.

I was having a conversation with my team recently and was told of being handed a slimy takeaway sushi in Japan, which had to be awkwardly disposed of á la Mr Bean, and of a very unsuccessful attempt to get the recipe for some delicious linguine from a German on-site chef. As we shared our food experiences, I began to notice just how ingrained our cultural expectations can be.

read more »